Company Description
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.
It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.
In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services.
The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Country | United States |
Founded | 1968 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 316,000 |
CEO | Samuel Hazen |
Contact Details
Address: One Park Plaza Nashville, Tennessee 37203 United States | |
Phone | 615 344 9551 |
Website | hcahealthcare.com |
Stock Details
Ticker Symbol | HCA |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000860730 |
CUSIP Number | 40412C101 |
ISIN Number | US40412C1018 |
Employer ID | 27-3865930 |
SIC Code | 8062 |
Key Executives
Name | Position |
---|---|
Samuel N. Hazen | Chief Executive Officer and Director |
Michael A. Marks | Chief Financial Officer and Executive Vice President |
Jon Mack Foster | Executive Vice President and Chief Operating Officer |
Michael R. McAlevey | Executive Vice President and Chief Legal and Administrative Officer |
Dr. Michael S. Cuffe M.B.A., M.D. | Executive Vice President and Chief Clinical Officer |
Dr. Thomas F. Frist Jr., M.D. | Founder and Chairman Emeritus |
Christopher F. Wyatt | Senior Vice President, Principal Accounting Officer and Controller |
Chad J. Wasserman | Senior Vice President and Chief Information Officer |
Frank George Morgan C.F.A. | Vice President of Investor Relations |
Wendy Warren | Senior Vice President, Chief Ethics and Compliance Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 14, 2025 | ARS | Filing |
Mar 14, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 14, 2025 | DEF 14A | Other definitive proxy statements |
Mar 4, 2025 | PRE 14A | Other preliminary proxy statements |
Feb 24, 2025 | 8-K | Current Report |
Feb 21, 2025 | 8-K | Current Report |
Feb 20, 2025 | 8-K | Current Report |
Feb 20, 2025 | 424B5 | Filing |
Feb 19, 2025 | FWP | Free Writing Prospectus |
Feb 18, 2025 | 8-K | Current Report |